opioid receptor agonist (IC50
values are 5.5 and > 10000 nM for inhibition of 125
I-FK 33,824 and 125
I-DADLE binding to μ
sites respectively). Produces naloxone-reversible analgesia, catalepsy and hyperthermia following central administration in rats in vivo
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Potent morphiceptin analogs: structure activity relationships and morphine-like activities.
Chang et al.
Behavioral effects of the μ-opioid peptide agonists DAMGO, DALDA and PL017 on locomotor activities.
Meyer and Meyer
Body temperature and analgesic effects of selective mu and kappa opioid receptor agonists microdialyzed into rat brain.
Xin et al.